Details of the Drug Reposition

General Information of This Drug (ID: DMHHXC9)

Drug Name
NSI-566   DMHHXC9
Synonyms
Neural stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Spinal cord stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Neural stem cell therapy (ALS, spinal cord injury, paraplegia, stroke), Neuralstem

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cerebrovascular ischaemia DISFSDLO 8B1Z Phase 2 [1]
Amyotrophic lateral sclerosis DISF7HVM 8B60.0 Phase 2 [2]
Lateral sclerosis DISH30B8 8B61 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Spinal cord injury DISOR9PQ ND51.2 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025566)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)